Enrichment with CSCs in the tumor spheres was confirmed by an increase in the CSC markers CD44, Nanog, EpCAM, and OCT4 (Figure1A; Figure S1A,B, Supporting Information). This evidence concerns the gene POU5F1 and neoplasm.